ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanazawa, H.
Right arrow Articles by Yoshikawa, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanazawa, H.
Right arrow Articles by Yoshikawa, J.
Eur Respir J 2003; 22:609-612
Copyright ©ERS Journals Ltd 2003


Imbalance between vascular endothelial growth factor and endostatin in emphysema

H. Kanazawa, K. Hirata and J. Yoshikawa

Dept of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan

CORRESPONDENCE: H. Kanazawa, Dept of Respiratory Medicine, Graduate School of Medicine, Osaka City University, 1-4-3, Asahi-machi, Abenoku Osaka, 545-8585, Japan. Fax: 81 666466808. E-mail: kanazawa-h@med.osaka-cu.ac.jp

Keywords: alveolar epithelial cells, angiogenic factors, apoptosis, pulmonary endothelial cells

Received: April 18, 2003
Accepted June 7, 2003

This work was supported by grant-in-aid for scientific research (1360611) from the Ministry of Education, Science and Culture, Japan.

Vascular endothelial growth factor (VEGF) stimulates endothelial cell proliferation, and endostatin directly antagonises the biological effects of VEGF. The maintenance of pulmonary endothelial cells is also thought to depend upon the local balance of VEGF and endostatin in the lung. Therefore, this study was designed to determine whether there is an imbalance between VEGF and endostatin levels in patients with pulmonary emphysema.

VEGF and endostatin levels were simultaneously measured from 25 emphysema patients and 12 normal control subjects, and their correlation and balance in induced sputum was evaluated.

VEGF levels in induced sputum were significantly lower in emphysema patients (854±307 pg·mL–1) than in normal controls (1,791±1,192 pg·mL–1). In contrast, there was no significant difference in endostatin levels among the two groups. Therefore, the ratio of VEGF to endostatin levels was markedly lower in emphysema patients (4.5±1.8) than in normal controls (8.1±2.6). Moreover, VEGF levels were correlated with endostatin levels in normal controls but not in emphysema patients. In addition, the ratio of VEGF to endostatin levels was correlated with forced expiratory volume in one second (FEV1), FEV1/forced vital capacity and carbon monoxide diffusing capacity of the lung in emphysema patients.

The findings in this study suggest that there is an imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from emphysema patients.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. J. Giordano, J. Lahdenranta, L. Zhen, U. Chukwueke, I. Petrache, R. R. Langley, I. J. Fidler, R. Pasqualini, R. M. Tuder, and W. Arap
Targeted Induction of Lung Endothelial Cell Apoptosis Causes Emphysema-like Changes in the Mouse
J. Biol. Chem., October 24, 2008; 283(43): 29447 - 29460.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. Yoshida and R. M. Tuder
Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Physiol Rev, July 1, 2007; 87(3): 1047 - 1082.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
V. Pinto-Plata, J. Toso, K. Lee, D. Park, J. Bilello, H. Mullerova, M. M De Souza, R. Vessey, and B. Celli
Profiling serum biomarkers in patients with COPD: associations with clinical parameters
Thorax, July 1, 2007; 62(7): 595 - 601.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. M. Henson, G. P. Cosgrove, and R. W. Vandivier
State of the Art. Apoptosis and Cell Homeostasis in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, August 1, 2006; 3(6): 512 - 516.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the European Respiratory Society.